Australian Cancer Technology
Vaccine adjuvant shows enhanced immune response in prostate cancer patients
Published in Health Risk Factor Week, March 29th, 2005
The results of the study data were reported in an electronic publication of the journal Vaccine (doi:10.1016/j.vaccine.2005.01.072). This is the first report of the use of GPI-0100 in humans.
The phase I study, led by Susan Slovin, MD, assistant professor of medicine at Memorial Sloan-Kettering Cancer Center, included patients with progressive prostate disease after primary surgery or radiotherapy. Patients had no...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Risk Factor Week
More Articles from Health Risk Factor Week
- Chinese Center for Disease Control & Prevention
Nutrient content of parental and genetically modified rice compared - Creighton University
Genetic link possible cause of bone marrow cancer - Indian Institute of Preventive Medicine
Rabies prophylaxis in malnourished children provides protection - Johns Hopkins University
Subsequent HPV risk in HIV+ women not lowered by natural infection - 3M
Alliance focuses on therapy for cervical high-risk HPV infection, dysplasia - AEterna Zentaris, Inc.
Biopharmaceutical firm appoints new members to its scientific advisory board - More from this issue of Health Risk Factor Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
